News by Tag: Pharma

Risk factors involved in PCD Pharma Franchise
A famous quote states “If you don’t take risks you’ll never know

July 17, 2021

How to increase sales in your PCD Business
The PCD pharma companies which give products, brand name and support to its partner franchise

July 13, 2021

What are the best products to start a PCD Pharma Franchise business?
The question of selecting the right product for a pharmaceutical franchise sometimes creates confusion.

July 12, 2021

How to identify generic medicine
What are generic drugs? A generic prescription is a product created in dosage form, protection

July 3, 2021

How PCD pharma franchise is more rewarding than other businesses?
Good businesses generate missions to drive their profits. Great businesses generate profits to drive their missions”; said a quote.

June 29, 2021

How to Proceed In Business with Pharma Franchise Concept
How to Begin PCD Pharma Franchise Business – Pharma Franchise Business is at boom organize in all over world.

June 19, 2021

SOTAX Group to Acquire Majority Stake in Ortiv-Q3
SOTAX not only strengthens its reach to a major geographic area but also gains access to new technical capabilities and resources that are built up within Ortiv.

June 15, 2021

Steps to Find a Genuine PCD Pharma Franchise
When you opt for becoming a pharma franchise owner

June 12, 2021

7 Key Rewards of Pharma Franchise Business
PCD Pharma Franchise is now one of the most profitable businesses in the existing drug market

June 12, 2021

GST on Medicines and Medical Supplies in India
The tax is imposed on goods and services in India at four None

June 11, 2021

Pharma PCD franchise in Jharkhand
PCD Pharma Franchise in Jharkhand | Penlon India Pvt. Ltd.

June 10, 2021

How to Prepare A Successful PCD Pharma Business Plan?
For every Pharma Geeks, who is trying to invest in PCD Pharma Franchise Business?

May 25, 2021

“Global Handheld Ultrasound Imaging Devices Market, 2020-2030”
An overview of the current market landscape of the handheld ultrasound imaging devices, providing information on the status of development

April 20, 2021

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners
According to industry experts, handheld ultrasound imaging devices are being adopted at a faster pace by different end-users owing to their higher efficiency and wider applicability.

April 20, 2021

Global handheld ultrasound imaging devices market
Roots Analysis has done a detailed study on “Global Handheld Ultrasound Imaging Devices Market, 2020-2030

April 20, 2021

Global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030
Advances in the field of disease diagnostics have led to a substantial increase in the development of point-of-care medical imaging devices

April 20, 2021

Global handheld ultrasound imaging devices market ,growing at a CAGR of 11%
The increasing medical diagnostic imaging burden has compelled industry players to develop advanced handheld ultrasound scanners that will enable physicians to accurately visualize all major organ systems for diagnostic purposes

April 20, 2021

“Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030”
A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals.

April 19, 2021

Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise.
The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise.

April 19, 2021

The nuclear medicine and radiopharmaceuticals manufacturing market grow at an annualized rate of over 10%,
Roots Analysis has announced the addition of “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report to its list of offerings.

April 19, 2021

Nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030
The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics

April 19, 2021

‘Biologics Fill / Finish Service Providers, 2019-2030’
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage)

April 19, 2021

Over 115 companies located in various regions across the globe claim to provide contract fill / finish services
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development

April 19, 2021

Contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%,
Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030., covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 19, 2021

Contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers

April 19, 2021

More than 100 industry players and over 60 non-industry players currently claim to manufacture different types of cell therapies.
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen

April 16, 2021

The cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030
Manufacturing cell therapies is technically and financially demanding; as a result, despite therapy developers gradually strengthening their in-house expertise

April 16, 2021

Growing at an annualized rate of over 16.5%,
Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity

April 16, 2021

‘Patient Recruitment and Retention Services, 2019-2030’
detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed

April 16, 2021

Presently, close to 140 companies claim to be actively engaged in offering patient recruitment
A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies

April 16, 2021

Patient recruitment and retention services market is projected to grow at an annualized rate of ~5%,
Roots Analysis has done a detailed study on Patient Recruitment and Retention Services Marker, 2019-2030.”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 16, 2021

Patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 2030,
A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment

April 16, 2021

More than 80 companies presently claim to have the required expertise to design and manufacture different types of labels.
Owing to the ever-increasing number of medical devices along with the rising associated complexities and stringent guidelines issued by various regulatory authorities

April 15, 2021

Medical device label contract manufacturing market is projected to grow at an annualized rate of ~9.8%,
Roots Analysis has done a detailed study on “Medical Device Labels Technology Market, 2019-2030 covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

April 15, 2021

The medical device label contract manufacturing market is projected to reach USD 509 million in 2030
Outsourcing the manufacturing of labels is a popular trend among medical device developers, enabling such companies to leverage the advanced capabilities of CMOs

April 15, 2021

Over 350 such drug candidates are being evaluated in the clinical stages of development (Roots Analysis)
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration

April 15, 2021

Subcutaneous biologic drugs is projected to be worth over USD 180 billion by 2030
Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030” covering key aspects of the industry and identifying future growth opportunities

April 15, 2021

Subcutaneous biologic drugs and affiliated technologies market (Roots Analysis)
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare

April 15, 2021

“HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030”
A detailed review of the overall landscape of companies offering contract services for the manufacturing of HPAPIs and cytotoxic drugs

April 14, 2021

Close to 120 companies across the globe claim to possess the required expertise (Roots Analysis)
Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment

April 14, 2021

Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs contract manufacturing (Roots Analysis)
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers

April 14, 2021

“Oligonucleotide Synthesis, Modification and Purification Services Market”
A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and diagnostic, and therapeutic applications.

April 14, 2021

More than 80 companies currently claim to offer manufacturing related services, at different scales of operations.
Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios

April 14, 2021

Modification and purification services market is projected to grow at an annualized rate of ~10%,
Roots Analysis has done a detailed study on “Oligonucleotide Synthesis, Modification and Purification Services Market: Focus on Research, Diagnostic and Therapeutic Applications, 2020-2030.””

April 14, 2021

The oligonucleotide synthesis market is estimated to be worth USD 5.8 billion in 2030,
The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis

April 14, 2021

‘Biologics Fill / Finish Service Providers, 2019-2030’ (By Roots Analysis)
A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage)

April 13, 2021

Over 115 companies located in various regions across the globe claim to provide contract fill / finish (Roots Analysis)
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols

April 13, 2021

Biologics market is projected to grow at an annualized rate of ~10%, (till 2030)
Vials represent the most prominent form of packaging used for biopharmaceutical interventions; with increasing demand for self-administration devices, syringes have also garnered significant attention

April 13, 2021

The contract fill / finish services market for biologics , (predicts Roots Analysis)
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers

April 13, 2021

‘Global Preventive Vaccines Market, 2020-2030’ (By Roots Analysis)
A detailed assessment of the current market landscape, including information on type of developer (industry, non-industry, industry / non-industry)

April 13, 2021

 138 123